(March 13, 2020, 1:32 PM EDT) -- BROOKLYN, N.Y. — A Canadian-based medical cannabis research, cultivation, processing and distribution company and certain of its executive officers violated U.S. securities laws by misrepresenting the financial and business benefits of a marketing and revenue-sharing agreement with another company, causing the company’s stock to trade at an artificially high rate, an investor alleges in a March 6 complaint filed in New York federal court (Chad Ganovsky v. Tilray Inc., et al., No. 20-1240, E.D. N.Y.)....